Ignite Creation Date:
2025-12-24 @ 2:25 PM
Ignite Modification Date:
2026-03-01 @ 10:11 AM
Study NCT ID:
NCT00664859
Status:
COMPLETED
Last Update Posted:
2020-03-24
First Post:
2008-04-21
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
12-Month, Open-Label, Extension Study of LCP-AtorFen in Dyslipidemia
Sponsor:
Veloxis Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
LCP-AtorFen-2001-1X
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None